BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12000778)

  • 1. Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment.
    Khan MA; Walley JD; Witter SN; Imran A; Safdar N
    Health Policy Plan; 2002 Jun; 17(2):178-86. PubMed ID: 12000778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
    Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directly observed therapy for treating tuberculosis.
    Karumbi J; Garner P
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003343. PubMed ID: 26022367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of an alternative tuberculosis management strategy for permanent farm dwellers in South Africa amidst health service contraction.
    Clarke M; Dick J; Bogg L
    Scand J Public Health; 2006; 34(1):83-91. PubMed ID: 16449048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis.
    Burman WJ; Dalton CB; Cohn DL; Butler JR; Reves RR
    Chest; 1997 Jul; 112(1):63-70. PubMed ID: 9228359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa.
    Floyd K; Wilkinson D; Gilks C
    BMJ; 1997 Nov; 315(7120):1407-11. PubMed ID: 9418087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan.
    Walley JD; Khan MA; Newell JN; Khan MH
    Lancet; 2001 Mar; 357(9257):664-9. PubMed ID: 11247549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy.
    McLaren ZM; Milliken AA; Meyer AJ; Sharp AR
    BMC Infect Dis; 2016 Oct; 16(1):537. PubMed ID: 27716104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil.
    Steffen R; Menzies D; Oxlade O; Pinto M; de Castro AZ; Monteiro P; Trajman A
    PLoS One; 2010 Nov; 5(11):e14014. PubMed ID: 21103344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
    Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of various tuberculosis control strategies in Thailand.
    Hunchangsith P; Barendregt JJ; Vos T; Bertram M
    Value Health; 2012; 15(1 Suppl):S50-5. PubMed ID: 22265067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment.
    Au-Yeung KY; DiCarlo L
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1498-504. PubMed ID: 23006834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia.
    Jacobs B; Clowes C; Wares F; Polivakho V; Lyagoshina T; Peremitin G; Banatvala N
    Int J Tuberc Lung Dis; 2002 May; 6(5):396-405. PubMed ID: 12019915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis.
    Palmer CS; Miller B; Halpern MT; Geiter LJ
    J Public Health Manag Pract; 1998 May; 4(3):1-13. PubMed ID: 10186738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
    Getahun B; Wubie M; Dejenu G; Manyazewal T
    Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis patient adherence to direct observation: results of a social study in Pakistan.
    Khan MA; Walley JD; Witter SN; Shah SK; Javeed S
    Health Policy Plan; 2005 Nov; 20(6):354-65. PubMed ID: 16183735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.
    Currie CS; Floyd K; Williams BG; Dye C
    BMC Public Health; 2005 Dec; 5():130. PubMed ID: 16343345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of community health worker versus home-based guardians for directly observed treatment of tuberculosis in Vitória, Espírito Santo State, Brazil.
    Prado TN; Wada N; Guidoni LM; Golub JE; Dietze R; Maciel EL
    Cad Saude Publica; 2011 May; 27(5):944-52. PubMed ID: 21655845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.